ImmuPharma's total assets for Q2 2022 were £2.88M, a decrease of -52.06% from the previous quarter. GB:IMM total liabilities were £858.52K for the fiscal quarter, a -45.81% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.